Tobramycin Blood Levels of CAPD Patients during Peritonitis

Abstract

Get full access to this article

View all access options for this article.

References

Khanna

, Oreopoulos

D.O.

, Dombros

, Vas

Continuous ambulatory peritoneal dialysis (CAPD) after three years: Still a promising treatment.

Peritoneal Dialysis Bulletin 1981; I: 24–34.

Williams

, Khanna

, Vas

S.I.

, Oreopoulos

Treatment of peritonitis in patients on CAPD: To lavage or not?

Peritoneal Dialysis Bulletin 1980; I: 14–17.

Vas

S.I.

, Low

D.E.

, Layne

, Khanna

, Dombros

Microbiological diagnostic approach to peritonitis in CAPD patients. In: Atkins

R.C.

, Thomson

N.M.

, Farrell

P.C.

. eds. Peritoneal dialysis. ChurchiII Livingstone 1981: 264–271.

Malacoff

R.F.

, Finkelstein

F.O.

, Andriole

V.T.

Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.

Antimicrob Agents Chemother 1975; 8: 574–580.

Gordon

R.C.

, Regamey

, Kirby

W.M.M.

Serum protein binding of the aminoglycoside antibiotics.

Antimicrob Agents Chemother 1972; 2: 214216.

Pancorbo

, Comty

Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis.

Antimicrob Agents Chemother 1981; 19: 605–607.

Blumenkrantz

M.I.

, Schmidt

R.W.

Nutritional management of the CAPD patient.

Peritoneal Dialysis Bulletin 1981; 1: 22–24.